Hearing Loss Trial, Recruiting NCT06453343 Sponsor: Radboud University Medical Center Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06453343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have hearing loss that developed after you learned to speak, and it has been confirmed by a doctor as a specific type called sensorineural hearing loss
  • You have been assessed as a suitable candidate for a cochlear implant based on your country's or local health system's guidelines
  • You are scheduled to receive a specific cochlear implant device called the CI632
  • The hearing test result for the ear being implanted shows a certain level of low-frequency hearing before the operation (confirm with trial site for details)
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You already have or have previously had a cochlear implant
  • There are blockages or unusual physical features in your inner ear that could make inserting the implant difficult
  • Scans (CT or MRI) have shown that the hearing nerve leading to your inner ear has an abnormal shape or structure
  • You are unable to have a CT or MRI scan for any reason
  • Your hearing loss is caused by damage to the hearing nerve or the hearing pathway in the brain
  • You have been diagnosed with a condition called auditory neuropathy, which affects how sound signals travel to the brain
  • You currently have an active infection in your middle ear
  • You have additional difficulties that would prevent you from completing the study assessments
  • You have expectations about the implant's benefits or risks that the trial team considers unrealistic
  • You are an employee of Cochlear (the company running this trial) or work for an organisation contracted by Cochlear for this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 024 361 14934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Residual hearing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov